Corey Davis, J.D., M.S.P.H., is deputy director of the Network’s Southeastern Region Office and the Director of the Harm Reduction Legal Project. Before joining NHeLP Corey served as Employment Rights Attorney at Equality Advocates Pennsylvania where he represented lesbian, gay, bisexual and transgender (LGBT) individuals before administrative commissions and in state and federal courts. Prior to joining Equality Advocates, Corey oversaw a street-based legal clinic sited at Philadelphia’s syringe exchange program. In both of these positions he provided direct legal representation as well as education, outreach and strategic advocacy.

Corey has also worked for the North Carolina Institute of Medicine, the University of Pennsylvania and the Drug Control and Access to Medicines Consortium in both research and management capacities. He is the recipient of the International AIDS Society’s Young Investigator Award, given for empirical research on the effect of law and law enforcement practice on access to an evidence-based public health intervention, and has published in the lay and academic press. Corey received his B.S. from the Indiana University of Pennsylvania, his M.S.P.H. from the University of North Carolina at Chapel Hill and his J.D. from Temple University. Corey is barred in Pennsylvania and New Jersey as well as various federal courts.
View a collection of research, resources and trainings produced by Corey below.

Articles & Resources

Congressional Efforts to Address Maternal Morbidity and Mortality

Law & Policy InsightsMaternal and Child Health

August 27, 2019
by Corey Davis

The United States is experiencing a crisis of maternal morbidity and mortality. Sixty percent of the roughly 700 deaths from pregnancy-related complications each year are considered preventable. In response, lawmakers have introduced a host of legislation aimed at improving maternal health and reducing the maternal mortality rate, particularly among those groups that are disproportionately impacted, including black and Hispanic mothers.

Read more

Overdose Prevention and Harm Reduction Law and Policy Update

Law & Policy InsightsOpioid Misuse and Overdose Prevention

March 21, 2019
by Corey Davis

The increase in drug-related harm that began over two decades ago continues to impact individuals and communities across the country. Partly due to this unprecedented and continuing rise in overdose-related harm, states and communities have taken a number of legal and policy steps to improve access to prevention and treatment. This post provides a few highlights, in no particular order.

Read more

Indian Health Service and Military Medical Prescription Drug Monitoring Program Requirements

Fact SheetSubstance Use Prevention and Harm ReductionOpioid Misuse and Overdose PreventionTribal Health

April 25, 2018
by Corey Davis

Prescription Drug Monitoring Programs (PDMPs) are state-run databases that collect information on specified medications at the point of dispensing. The data is available to medical professionals and others, as permitted by relevant law. PDMPs can help clinicians improve decisions regarding opioid prescribing.

View page

Litigation Against Opioid Manufacturers: Lessons from the Tobacco Wars

WebinarsOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

March 15, 2018
by Corey Davis

Dozens of state, local, and tribal governments have sued opioid pain reliever manufacturers for their alleged role in fueling the opioid overdose epidemic, and 41 state attorneys general are investigating potential unlawful sales and marketing practices by these manufacturers. Although these investigations and lawsuits appear similar to those against the tobacco industry during the 1990s, states should mindful of the important ways in which they differ.

View page

Public Health Emergency Declaration Falls Short of Expanding Access to Opioid Use Disorder Treatment in Rural Communities

Law & Policy InsightsPublic Health Emergency: Legal Preparedness & Response

January 8, 2018
by Corey Davis

The number of Americans affected by the opioid epidemic has reached staggering rates. In 2016, more Americans died from drug overdoses than died through the entirety of the Vietnam War. Fortunately, there is an effective, evidence-based way of treating opioid use disorder (OUD) – treatment with the medications methadone and buprenorphine, which is termed medication-assisted treatment (MAT).

Read more

The Negative Impacts of Eliminating ACA Cost-Sharing Reduction Payments

Law & Policy InsightsHealth Reform

December 15, 2017
by Corey Davis

Nearly 4.7 million Americans, including 1.3 million new enrollees, signed up for health care through the Affordable Care Act’s marketplaces, and polling indicates the public has a favorable opinion of the law. Nevertheless, after failing in their full-scale attempt to repeal and replace the Affordable Care Act (ACA), Congressional Republicans and the Trump Administration continue to put individual pieces of the legislation at risk of elimination.

Read more

From 0 to 50: The Rapid Adoption of Naloxone Access Laws in the U.S.

Law & Policy InsightsSubstance Use Prevention and Harm ReductionOpioid Misuse and Overdose Prevention

July 26, 2017
by Corey Davis

The opioid overdose epidemic is a continuing public health crisis. When we began tracking laws aimed to increase access to naloxone in late 2012, they existed in only eight states. As of July 1, 2017, every state and Washington D.C. has passed at least one law increasing access to naloxone—a remarkably rapid progression for public health legislation.

Read more